SHREWSBURY, N.J., Oct. 28, 2015 (GLOBE NEWSWIRE) -- InterCloud Systems, Inc. (Nasdaq:ICLD) (the “Company” or “InterCloud”), a leading provider of cloud networking orchestration and automation solutions and services announced today it has been selected by a Massachusetts based Pharmaceutical company to provide a cloud based data protection and replication service. InterCloud will provide key value add elements including geographic data redundancy to guard critical customer data against any colossal failure, natural disaster or human error. In addition, InterCloud will provide a total turnkey implementation including design, implementation, integration and managed services.
Mark Munro, CEO of InterCloud, stated, “We are pleased to report this new business relationship. InterCloud’s cloud data protection and disaster recovery services are expected to be provisioned immediately and will safeguard our customer’s critical data against any unforeseen harmful events. Our team at Vaultlogix made a tremendous effort to design an industry leading solution for this application.”
Mr. Munro continued; “It has been a little over a year since we closed the acquisition of Vaultlogix and it has exceeded our expectations with its financial results. Vaultlogix has grown its topline revenue in 2015 and a run rate EBITDA growth of over 20% through end of Q-2 2015 versus the same time period in 2014. We could not possibly be more pleased with the growth in our cloud data protection platform results. This is the model for our future with a vast majority of recurring revenues.”
About InterCloud Systems, Inc.
InterCloud Systems, Inc. is a leading provider of cloud networking orchestration and automation, for Software Defined Networking (SDN) and Network Function Virtualization (NFV) cloud environments to the communications service provider and corporate enterprise markets, through cloud solutions and professional services. Additional information regarding InterCloud may be found on InterCloud's website at www.intercloudsys.com.
Forward-looking statements:
The above news release contains forward-looking statements. The statements contained in this document that are not statements of historical fact, including but not limited to, statements identified by the use of terms such as “anticipate,” “appear,” “believe,” “could,” “estimate,” “expect,” “hope,” “indicate,” “intend,” “likely,” “may,” “might,” “plan,” “potential,” “project,” “seek,” “should,” “will,” “would,” and other variations or negative expressions of these terms, including statements related to expected market trends and the Company’s performance, are all “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and involve a number of risks and uncertainties. These statements are based on assumptions that management believes are reasonable based on currently available information, and include statements regarding the intent, belief or current expectations of the Company and its management. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performances, and are subject to a wide range of external factors, uncertainties, business risks, and other risks identified in filings made by the company with the Securities and Exchange Commission. Actual results may differ materially from those indicated by such forward-looking statements. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statement contained herein to reflect any change in the company’s expectations with regard thereto or any change in events, conditions or circumstances upon which any statement is based except as required by applicable law and regulations.